Detalles de la búsqueda
1.
RIPK4 regulates cell-cell adhesion in epidermal development and homeostasis.
Hum Mol Genet;
31(15): 2535-2547, 2022 08 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-35220430
2.
Association between maternal dupilumab exposure and pregnancy outcomes in patients with moderate-to-severe atopic dermatitis: A nationwide retrospective cohort study.
J Eur Acad Dermatol Venereol;
2024 Jan 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38284131
3.
Dupilumab significantly improves sleep in adults with atopic dermatitis: results from the 12-week placebo-controlled period of the 24-week phase IV randomized double-blinded placebo-controlled DUPISTAD study.
Br J Dermatol;
189(6): 685-694, 2023 11 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37562034
4.
Tildrakizumab improves high burden skin symptoms, impaired sleep and quality of life of moderate-to-severe plaque psoriasis patients in conditions close to clinical practice.
J Eur Acad Dermatol Venereol;
37(10): 2004-2015, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37246505
5.
Secukinumab demonstrates superiority over narrow-band ultraviolet B phototherapy in new-onset moderate to severe plaque psoriasis patients: Week 52 results from the STEPIn study.
J Eur Acad Dermatol Venereol;
37(5): 1004-1016, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36606536
6.
Real-life effectiveness and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: A 104-week multicenter retrospective study - IL PSO (ITALIAN LANDSCAPE PSORIASIS).
J Eur Acad Dermatol Venereol;
37(5): 1017-1027, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36695061
7.
Real-life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52-week multicentre retrospective study-IL PSO (Italian landscape psoriasis).
J Eur Acad Dermatol Venereol;
37(1): 93-103, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36156312
8.
Upadacitinib plus topical corticosteroids in atopic dermatitis: Week 52 AD Up study results.
J Allergy Clin Immunol;
149(3): 977-987.e14, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34403658
9.
Real-life efficacy of guselkumab in patients with early psoriatic arthritis.
Rheumatology (Oxford);
61(3): 1217-1221, 2022 03 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34152379
10.
The biological basis of disease recurrence in psoriasis: a historical perspective and current models.
Br J Dermatol;
186(5): 773-781, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34939663
11.
Anti-IL17 and anti-IL23 biologic drugs for scalp psoriasis: A single-center retrospective comparative study.
Dermatol Ther;
35(2): e15228, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34820969
12.
Apremilast for the treatment of palmo-plantar non-pustular psoriasis: A real-life single-center retrospective study.
Dermatol Ther;
35(2): e15253, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34877758
13.
Real life long-term efficacy and safety of ixekizumab in moderate-to-severe psoriasis: A 192 weeks multicentric retrospective study-IL PSO (Italian landscape psoriasis).
Dermatol Ther;
35(8): e15608, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35638250
14.
Real-world evidence of biologic treatments in moderate-severe psoriasis in Italy: Results of the CANOVA (EffeCtiveness of biologic treAtmeNts for plaque psOriasis in Italy: An obserVAtional longitudinal study of real-life clinical practice) study.
Dermatol Ther;
35(1): e15166, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34676662
15.
Real-World Treatment Patterns and Treatment Benefits among Adult Patients with Atopic Dermatitis: Results from the Atopic Dermatitis Patient Satisfaction and Unmet Need Survey.
Acta Derm Venereol;
102: adv00830, 2022 Dec 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36479885
16.
Comparative effectiveness of biologics in clinical practice: week 12 primary outcomes from an international observational psoriasis study of health outcomes (PSoHO).
J Eur Acad Dermatol Venereol;
36(11): 2087-2100, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35766124
17.
Urban Seismic Network Based on MEMS Sensors: The Experience of the Seismic Observatory in Camerino (Marche, Italy).
Sensors (Basel);
22(12)2022 Jun 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35746124
18.
Incidence rates of hospitalization and death from COVID-19 in patients with psoriasis receiving biological treatment: A Northern Italy experience.
J Allergy Clin Immunol;
147(2): 558-560.e1, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33160968
19.
Real-life Effectiveness and Safety of Risankizumab in Moderate-to-severe Plaque Psoriasis: A 40-week Multicentric Retrospective Study.
Acta Derm Venereol;
101(11): adv00605, 2021 Nov 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34596230
20.
Secukinumab Improves Patient Perception of Anxiety and Depression in Patients with Moderate to Severe Psoriasis: A Post hoc Analysis of the SUPREME Study.
Acta Derm Venereol;
101(3): adv00422, 2021 03 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-33269404